Eligibility Matcher
Select your organization type below to see only the grants you qualify for — sorted by soonest deadline.
Native American tribal organizations (other)Nonprofits having 501(c)(3) statusNonprofits without 501(c)(3) statusPrivate institutions of higher educationIndividualsFor-profit organizationsSmall businessesOthersUnrestrictedState governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic/State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities
449 grants for Special district governments
Sorted by deadline (soonest first)
Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)
HHS-NIH11 · PAR-25-311
Closes Nov 15, 2027
Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-336
Closes Nov 15, 2027
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
HHS-NIH11 · PAR-25-265
Closes Nov 16, 2027
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-122
Closes Nov 16, 2027
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
HHS-NIH11 · PAR-25-266
Closes Nov 16, 2027
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-244
Closes Nov 16, 2027
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-068
Closes Nov 16, 2027
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
HHS-NIH11 · RFA-DA-26-034
Closes Nov 18, 2027
Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
HHS-NIH11 · RFA-DA-26-055
Closes Dec 3, 2027
Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
HHS-NIH11 · RFA-DA-26-056
Closes Dec 3, 2027
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)
HHS-NIH11 · RFA-HL-26-019
Closes Dec 23, 2027
Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)
HHS-NIH11 · RFA-HL-26-020
Closes Dec 23, 2027
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
HHS-NIH11 · RFA-HL-26-016
Closes Dec 23, 2027
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
HHS-NIH11 · RFA-HL-26-018
Closes Dec 23, 2027
Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
HHS-NIH11 · RFA-HL-26-017
Closes Dec 23, 2027
NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
HHS-NIH11 · PAR-25-188
Closes Jan 6, 2028
NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
HHS-NIH11 · PAR-25-057
Closes Jan 6, 2028
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
HHS-NIH11 · PAS-25-205
Closes Jan 6, 2028
Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)
HHS-NIH11 · PAR-25-062
Closes Jan 6, 2028
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
HHS-NIH11 · PAR-25-144
Closes Jan 7, 2028
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
HHS-NIH11 · PAR-25-143
Closes Jan 7, 2028
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-233
Closes Jan 7, 2028
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-286
Closes Jan 7, 2028
Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-203
Closes Jan 7, 2028
Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
HHS-NIH11 · PAR-25-227
Closes Jan 7, 2028